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Abstract
Background: Infection with parvovirus B19 may cause fetal losses including spontaneous abortion,
intrauterine fetal death and non-immune hydrops fetalis. The aim of this study is to determine the
frequency of parvovirus B19 in formalin fixed placental tissues in lost fetuses using real-time PCR
method.
Methods: In this cross-sectional study, 100 formalin fixed placental tissues with unknown cause of
fetal death were determined using real-time PCR method after DNA extraction.
Results: Six out of 100 cases (6%) were positive for parvovirus B19 using real-time PCR. Gesta-
tional age of all positive cases was less than 20 weeks with a mean of 12.3 weeks. Three cases have a
history of abortion and all of positive cases were collected in spring. Mean age of positive cases were
28 years.
Conclusion: Parvovirus B19 during pregnancy can infect red precursor cells and induces apoptosis
or lyses these cells that resulting in anemia and congestive heart failure leading to fetal death. Man-
agement of parvovirus B19 infection in pregnant women is important because immediate diagnosis
and transfusion in hydropsic fetuses can decrease the risk of fetal death.
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Introduction
Parvoviruses are small DNA-containing
viruses, single-stranded and none envel-
oped. Parvo B19V (Parvovirus B19) be-
longs to Erythro-viruses genus that is path-
ogenic for humans. B19V has three major
viral proteins, one non-structural protein
NS1 (77 kDa), two structural proteins VP1
(83 kDa) and VP2 (53 kDa and two minor
proteins (1,2). NS1 has important role in
activation of viral gene tr anscription, viral
replication and induces apoptosis in target
cells. This protein cause cell death by apop-
tosis by the pathway caspase 3 and is inhib-
ited by Bcl-2 (3).
P antigen is the most important cellular
receptor for B19V (4), which is a glycol
sphingo lipid globoside that exists on the
surfaces of progenitors erythrocyte cells,
endothelium, synovium, placental tropho-
blast, myocardial cells and fetal hepatic
cells (4,5). B19V have no polymerase of its
own: this virus needs active cell division
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for replication. Like other Parvo viruses,
B19V induces cells into S phase for own
replication. Having a large number of cells
in mitosis makes fetuses vulnerable to
B19V. The most important of these precur-
sors cells are CFU-E (erythroid colony
forming units) and BFU-E (erythroid burst-
forming units); B19V simply infect and
replicate in this cells (2,6,7). In addition to
cytolytic activity, B19V has an apoptosis
inducing factor, and an ability to arrest cells
at either G1 or G2 cell cycle phases. So,
B19V can destruct many of erythroid pro-
genitor cells that leads to anemia (8).
Moreover, B19V may infect platelets, lym-
phocytes and granulocytes. Infection with
B19V mostly occurs through respiratory
droplets; other ways of transmission are
blood and blood-derived products and ver-
tical transmission from mother to fetus (9).
Rate of vertical transmission in maternal
infection is 33–51% of cases, and the rate
of adverse fetal effect is approximately
10% (10,11). B19V is the most important
infectious cause of fetal anemia. Fetuses
during the hepatic stage of hematopoiesis
are severely affected by B19V infection
and they are noticeably vulnerable (12).
The rate of incidence of fetal mortality and
morbidity related to B19V infection depend
on gestational age (9,13). Decreasing the
rate of fetal losses after 25 weeks is related
to passive transfer of maternal antibodies
and decreasing expression of P antigen
within the villous trophoblast layer (14).
Fetal infection with B19V is related to
non-immune hydrops fetalis (NIHF), intra-
uterine fetal death (IUFD), myocarditis,
thrombocytopenia, and neurological mani-
festations. Fetal infection may also remain
clinically unrecognized (15).
B19V infection-associated fetal death and
hydrops fetalis occur mostly during the se-
cond trimester (16). The aim of the current
study was to determine the relation between
parvovirus B19 infection and fetal mortali-




In this cross sectional study, 100 formalin
fixed placental tissues from autopsies done
following fetal-loss cases including sponta-
neous abortion and non-immune hydrops
fetalis and IUFD. Autopsies were done in
2012 at obstetrics and gynecology medical
center hospital, affiliated to Arak Universi-
ty of medical sciences. Patients were admit-
ted from all regions of markazi state, repre-
senting a wide spectrum of socioeconomic
levels.
Detailed clinical, autopsy and placental
examination reports were reviewed on all
100 tissue samples. The time from the last
menstruation was used for calculation of
gestational age.
DNA Extraction
For nucleic acid isolation specimens were
frozen and thawed for three times; then
DNA was extracted using Nucleic Acid iso-
lation kit (Roche Applied Science) as de-
scribed by the manufacturer. Genome was
re-suspended in a final volume of 100μl
elution buffer and stored at -80 °C.
Real time PCR
The primers and TaqMan probe for quan-
titative real-time PCR were selected from
the most conserved sequences encoding the
non-structural protein (NS1) of parvovirus
B19 viruses  using the “Beacon Designer”
software program (PREMIER Biosoft In-
ternational, USA) (Table1).
Reactions were performed using Univer-
sal TaqMan Master Mix (Applied Bio sys-
tems) in a final volume of 25µL with pri-
Table1. Sequence primer and probe
Name Sequence Position
PB forward 5´-AATGCAGATGCCCTCCACG-3´ 1468–1485
PB Reverse 5´-ATGATTCTCCTGAACTGGTCCA-3´ 1740–1760
PB Probe 5´-FAM-AACCCCGCGCTCTAGTACCGA-TAMARA-3´ 1711–1728
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mers and probe at a concentration of 30 and
100 nM, respectively. Following initial in-
cubations at 50°C for 2 minutes and 95°C
for 15 minutes, 40 cycles of thermal cy-
cling at 95°C for 15 seconds and 60°C for
40 seconds were performed in a CFX96
BioRAD real-time system. Data were col-
lected in FAM channel.
PVB19- infected bone marrow tissue
from a patient suffering from acute aplastic
anemia served as a positive control that was
tested with a commercial real-time PCR kit
(Inter Lab Service, Russia). All samples
were analyzed in duplicate.
Statistical analysis
The data were analyzed using SPSS 19.
The relation between parvovirus B19 posi-
tivity and the time of sample collection was
analyzed using chi-square test. A P-value
of <0.05 was considered statistically signif-
icant.
Result
Samples were collected during 2012 from
idiopathic abortions. Six cases infected
with parvovirus B19 (6%) occurred in 10,
11, 11, 13, 13 and 16 weeks gestational
age. Mean (±SD) gestational age of infect-
ed cases is12.6 (±3.4) weeks. All of those
fetal losses infected by B19 V were less
than 20 weeks of gestational age. All posi-
tive cases were found in spring; the season-
al prevalence of fetal death related to par-
vovirus B19 was statistically meaningful (P
value<0.001) (Fig. 1).
Moreover, 3 cases out of 6 cases had a
history of abortion or intrauterine fetal
death (IUFD). All of infected cases de-
clared a history of contact with children
and these cases were anemic. Number of
pregnancies of positive cases was in a
range of 1 to 5. One of the infected cases
was aborted in first pregnancy (Table 2).
Discussion
Parvovirus B19 is an infectious agent re-
sults in fetal losses during pregnancy.
B19V during pregnancy can kill red cell
precursors resulting in anemia and conges-
tive heart failure and finally fetal death can
occur. Within late gestation no signs of fe-
tal involvement might happen (17,19). So,
the rate of parvovirus B19 is higher than we
conceive. Determination of etiology of the
anemia and hydrops is very important. If
the cause of hydrops is B19V, the intrauter-
ine blood transfusion is very critical and
chance of fetal survival can improve 60%
to 80%; in other hand, in untreated cases
this rate is 15% to 30% (20,21-23). In our
cross-sectional study, with the aim of de-
Fig.1. comparative prevalence of parvovirus
B19 infection in different season
Table 2. Findings and their relation with seasonal incidence, gestational age, number of pregnancies and contact with
children
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termination of the frequency of parvovirus
B19 infection in fetal losses from 100 sam-
ples, 6 samples (6%) of dead fetuses were
infected with B19V. Other studies conduct-
ed in Tehran (10%), Tunisia (17.24%),
Brazil (5.9%) and Greece showed similar
results (24-27).
In another study conducted by Thomas
Tolfeveston et al, from 47 cases of fetal
death, 7 cases were infected by parvovirus
B19 (28). Our study have similar result and
the small differences might be related to
specimen pupulation.
The outcome of intrauterine parvovirus
B19 infection is not completely known and
is related to factors such as variations of
viral spread or gestational age of subjects
and other causes also may be responsible
for fetal death such as chromosomal ab-
normalities (29). Women with confirmed
infection show a significantly higher rate of
second-trimester fetal loss (11.8%) com-
pared with the control group (30, 31).
This study that evaluated the relation be-
tween fetal losses and the infection caused
by B19 virus, have several important and
noticeable results: fetal losses were affected
by this virus occurred in different ages
from 10 to 16 weeks, but all 6 positive cas-
es occurred in less than 20 week of gesta-
tional age. In similar studies conducted by
Hamkar et al (27) (on 31 placental tissues)
and Enders at al. (on 1018 cases) (32), all
of fetal deaths had occurred less than 20
weeks.
The yearly peak prevalence of infection
happens in spring; in addition, larger epi-
demics happen every 4 years (33). In our
study all positive cases of this study were
detected in spring. Our findings also
showed that 3 positive cases had a history
of abortion or intrauterine fetal losses. So,
more studies are needed to study the exact
role of this virus in continual abortion. The
limitation of this study was lack of access
to patients’ serum to study the level of anti-
body. Although we screened all samples,
other causes of fetal losses such as taking
drugs for abortion, trauma, genetic factors
and etc should be evaluated. Therefore, it
cannot certainly be proved that virus was
the main cause of fetal losses. It is also ad-
vised to do serologic test before pregnancy,
because 34 to 65% women are sensitive to
parvovirus B19 in different parts of the
world (34).
The most important risk factors for expo-
sure to B19V are having contact with
young children and also the number of
children at home (35, 36).
This virus is easily transferred by small
children at school. We suggest another
study with control group at the time of the
prevalence of this virus. It is also recom-
mended that high-risk women, for example
teachers and daycare workers, be monitored
for parvovirus. If hydrops fetalis is suspect-
ed in these groups, reviewing prenatal find-
ings can help in finding the etiology and
management can be started sooner. Evalua-
tion of the role of this virus in continual
and repeated abortions is also suggested.
Conclusion
This study showed that fetal mortality is
probably associated with parvovirus B19
infection in its peak prevalence time. Im-
mediate diagnosis and management of par-
vovirus B19 infection in pregnant women is
important and transfusion in hydropic fe-
tuses can decrease the risk of fetal death.
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